Pterodonoic acid

Details

Top
Internal ID 6a5cae65-e511-4256-828c-2620c2696766
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Eudesmane, isoeudesmane or cycloeudesmane sesquiterpenoids
IUPAC Name 2-[(2R,4aS)-4a,8-dimethyl-7-oxo-1,2,3,4,5,6-hexahydronaphthalen-2-yl]prop-2-enoic acid
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C15H20O3/c1-9(14(17)18)11-4-6-15(3)7-5-13(16)10(2)12(15)8-11/h11H,1,4-8H2,2-3H3,(H,17,18)/t11-,15+/m1/s1
InChI Key RDGFGQJFNSCICW-ABAIWWIYSA-N
Popularity 13 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H20O3
Molecular Weight 248.32 g/mol
Exact Mass 248.14124450 g/mol
Topological Polar Surface Area (TPSA) 54.40 Ų
XlogP 2.50
Atomic LogP (AlogP) 3.11
H-Bond Acceptor 2
H-Bond Donor 1
Rotatable Bonds 2

Synonyms

Top
62458-42-8
orb1680282
CHEMBL4067217
AKOS040763488
FS-8287

2D Structure

Top
2D Structure of Pterodonoic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9929 99.29%
Caco-2 + 0.7555 75.55%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.5429 54.29%
Subcellular localzation Mitochondria 0.8352 83.52%
OATP2B1 inhibitior - 0.8508 85.08%
OATP1B1 inhibitior + 0.9116 91.16%
OATP1B3 inhibitior + 0.9109 91.09%
MATE1 inhibitior - 0.7600 76.00%
OCT2 inhibitior + 0.6000 60.00%
BSEP inhibitior - 0.7744 77.44%
P-glycoprotein inhibitior - 0.9138 91.38%
P-glycoprotein substrate - 0.8780 87.80%
CYP3A4 substrate + 0.5481 54.81%
CYP2C9 substrate - 0.8078 80.78%
CYP2D6 substrate - 0.9114 91.14%
CYP3A4 inhibition - 0.7249 72.49%
CYP2C9 inhibition - 0.9167 91.67%
CYP2C19 inhibition - 0.9066 90.66%
CYP2D6 inhibition - 0.9306 93.06%
CYP1A2 inhibition - 0.7173 71.73%
CYP2C8 inhibition - 0.8890 88.90%
CYP inhibitory promiscuity - 0.9467 94.67%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.5509 55.09%
Eye corrosion - 0.9931 99.31%
Eye irritation + 0.5690 56.90%
Skin irritation + 0.6281 62.81%
Skin corrosion - 0.9424 94.24%
Ames mutagenesis - 0.6100 61.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5950 59.50%
Micronuclear - 0.6800 68.00%
Hepatotoxicity + 0.5637 56.37%
skin sensitisation - 0.5547 55.47%
Respiratory toxicity - 0.5556 55.56%
Reproductive toxicity + 0.8667 86.67%
Mitochondrial toxicity + 0.8125 81.25%
Nephrotoxicity + 0.6539 65.39%
Acute Oral Toxicity (c) III 0.8152 81.52%
Estrogen receptor binding - 0.6019 60.19%
Androgen receptor binding - 0.5000 50.00%
Thyroid receptor binding - 0.6694 66.94%
Glucocorticoid receptor binding - 0.6277 62.77%
Aromatase binding - 0.6132 61.32%
PPAR gamma + 0.7204 72.04%
Honey bee toxicity - 0.9102 91.02%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.6100 61.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 94.67% 83.82%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.11% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.99% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.37% 96.09%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 86.93% 99.23%
CHEMBL1902 P62942 FK506-binding protein 1A 86.35% 97.05%
CHEMBL2581 P07339 Cathepsin D 85.67% 98.95%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 84.25% 93.00%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 84.05% 93.03%
CHEMBL253 P34972 Cannabinoid CB2 receptor 83.44% 97.25%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 82.37% 93.04%
CHEMBL5608 Q16288 NT-3 growth factor receptor 81.01% 95.89%

Cross-Links

Top
PubChem 11054003
NPASS NPC23694
LOTUS LTS0240551
wikiData Q105234200